Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Avenzoar Pharmaceuticals Inc
Profile last edited on: 3/10/20      CAGE: 7PHF5      UEI: PJD2JB2E2L11

Business Identifier: Cancer drugs aiming at targeting and inhibiting mechanisms of metastasis and drug resistance
Year Founded
2016
First Award
2019
Latest Award
2019
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

662 Encinitas Boulevard Suite 248
Encinitas, CA 92024
   (310) 502-0770
   N/A
   www.avenzoarpharmaceuticals.com
Location: Single
Congr. District: 49
County: San Diego

Public Profile

Avenzoar Pharmaceuticals Inc is a pharmaceutical company focused on developing cancer drugs aimed at targeting and inhibiting mechanisms of metastasis and drug resistance.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$212,201
Phase II Dollars
$0
Total Awarded
$212,201

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 1 NIH $212,201
Project Title: A Dual Histone Deacetylase and Glycogen Synthase Kinase 3 Beta Inhibitor for Treating Pancreatic Adenocarcinoma

Key People / Management

  Terrance Bruggeman -- President

  Mouad Edderkaoui -- Chief Science Officer

Company News

There are no news available.